Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine
about
Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in manRole of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responsesPlatelet-activating factor: receptors and signal transductionBacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia.Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells.Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heartKinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.Monocyte chemoattractants in pigeon aortic atherosclerosis.Altered inflammatory responses in leukotriene-deficient miceHuman endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombinArachidonic acid metabolism in polymorphonuclear leukocytes from patients with chronic granulomatous diseaseAcetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes.Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.E-type prostaglandins but not iloprost inhibit platelet activating factor-induced generation of leukotriene B4 by human polymorphonuclear leukocytes.Accumulation of phosphatidic acid mass and increased de novo synthesis of glycerolipids in platelet-activating-factor-activated human neutrophils.Studies on the activation of human neutrophil 5-lipoxygenase induced by natural agonists and Ca2+ ionophore A23187Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.Paf-induced release of spasmogens from guinea-pig lungs.Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.A PAF receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma.Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor.
P2860
Q28326803-6BC399A7-03E0-49A8-81B7-876A6E303025Q28505542-995AFAE9-9B60-4DF6-B70A-C3664EFD233CQ28609556-A11B033D-BA88-4F43-BC3D-5B8E0319286CQ33596425-CE11DD21-3A52-4A21-B72F-43A19269EFDEQ34608616-8B119F14-254B-4DB6-AAAE-3ECBA82AD30EQ35812031-FB56891F-557A-4BED-8214-7968EAC959B0Q35835401-E9D7427C-E5DB-485A-9D46-6A65DEB003D7Q35856075-FC7B67EA-2093-40CF-9484-3813C03C6B68Q36008360-046D7FE5-AE34-4114-B006-F5EDA9C94755Q36270379-412CA0FA-A73E-4D1C-835E-47B903C243C3Q36349368-DFD9C3DC-1699-40DB-95B2-4F1F56D5A4D0Q40681712-97067AA7-686D-4928-8051-C8A0DFD4CA00Q41202814-7DFDA347-E34A-423B-9A5C-DEA793ACEF69Q41834589-4B88AAA6-29BB-4A53-8991-FDFAC5406BCAQ41849590-A74238E8-040B-45FF-99FC-13331D40046CQ41938957-4D023A1C-8367-4332-8EFF-FA77171C8AD7Q42028772-3967D769-4A0A-4147-8C55-F2021ED255A3Q42051045-94377583-21BD-4EC0-A9B5-82EA9F92A7CEQ42075404-05BE79A0-CA9B-43EC-877C-188252DCBE5CQ42226119-BC9C2B2B-3A7D-4C2E-A4BF-D5F9E5CCABD1Q42848304-1FBA9774-5DE2-41BA-AF1E-E84ED901E8FFQ42849846-4363CC5F-615F-4FBA-80FE-6B7119B1F157Q43203853-D0C3BBF4-D84A-4305-9AC2-848C1483BCD1Q43213297-943700A3-4BC2-4DC5-8B7B-C93B86170771
P2860
Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine
description
1982 nî lūn-bûn
@nan
1982 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@ast
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@en
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@nl
type
label
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@ast
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@en
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@nl
prefLabel
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@ast
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@en
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@nl
P2093
P1476
Platelet activating factor. St ...... yl-sn-glycero-3-phosphocholine
@en
P2093
Chilton FH
DeChatelet LR
O'Flaherty JT
P304
P407
P577
1982-05-01T00:00:00Z